Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CTSA | P10619 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3369026 | 0.90 | TSHR (0.32) | TSHR | |
| SCHEMBL28577036 | 0.85 | — | — | |
| SCHEMBL27555975 | 0.82 | TSHR (0.48) | TSHRACHE | |
| SCHEMBL4028324 | 0.79 | TSHR (0.32) | TSHR | |
| SCHEMBL22653 | 0.79 | — | — | |
| SCHEMBL6041232 | 0.79 | TSHR (0.32) | TSHR | |
| SCHEMBL6998228 | 0.77 | SMPD1 (0.32) | TSHR | |
| SCHEMBL28830260 | 0.77 | SMPD1 (0.32) | TSHR | |
| SCHEMBL27337812 | 0.77 | TSHR (0.43) | TSHRACHE | |
| SCHEMBL8724557 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 643 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120138118-A | Nucleic acid sequencing method and sequencing kit | 赛纳生物科技(北京)有限公司 | 2025-06-13 | — | — | CN | claimed |
| US-20250112328-A1 | Separator and Lithium Secondary Battery Including the Same | LG CHEM, LTD. (KR) | 2025-04-03 | — | — | US | claimed |
| EP-4468500-A1 | SEPARATOR AND LITHIUM SECONDARY BATTERY COMPRISING SAME | LG Chem, Ltd. (KR) | 2024-11-27 | — | — | EP | claimed |
| CN-118922536-A | Segmented nucleic acids | 钟明宏 | 2024-11-08 | — | — | CN | claimed |
| CN-118525417-A | Separator and lithium secondary battery including the same | 株式会社LG化学 | 2024-08-20 | — | — | CN | claimed |
| CN-117254103-A | Lithium ion battery electrolyte and lithium ion battery | 浙江蓝天环保高科技股份有限公司 | 2023-12-19 | — | — | CN | claimed |
| CN-116936913-A | Fluorinated carboxylic ester composition for high-voltage electrolyte and electrolyte thereof | 浙江蓝天环保高科技股份有限公司 | 2023-10-24 | — | — | CN | claimed |
| WO-2023146315-A1 | SEPARATOR AND LITHIUM SECONDARY BATTERY COMPRISING SAME | 주식회사 엘지화학 | 2023-08-03 | — | — | WO | claimed |
| CN-114656433-A | Thioisoprophorone bridge modified double-donor organic optical nonlinear chromophore and synthetic method and application thereof | 广州大学 | 2022-06-24 | — | — | CN | claimed |
| CN-111106384-B | Electrolyte matched with high-nickel anode lithium ion battery | 中国科学院福建物质结构研究所 | 2021-02-12 | — | — | CN | claimed |
| CN-111106384-A | Electrolyte matched with high-nickel anode lithium ion battery | 中国科学院福建物质结构研究所 | 2020-05-05 | — | — | CN | claimed |
| CN-103068834-B | Phosphoramidites for reverse RNA synthesis | 坎姆根公司 | 2016-10-26 | — | — | CN | claimed |
| US-9365607-B1 | Synthesis of deuterated ribo nucleosides, N-protected phosphoramidites, and oligonucleotides | ASED, LLC (US) | 2016-06-14 | — | — | US | claimed |
| EP-2560982-A2 | PHOSPHORAMIDITES FOR SYNTHETIC RNA IN THE REVERSE DIRECTION | Chemgenes Corporation (US) | 2013-02-27 | — | — | EP | claimed |
| WO-2011103468-A2 | PHOSPHORAMIDITES FOR SYNTHETIC RNA IN THE REVERSE DIRECTION | CHEMGENES CORPORATION (US) | 2011-08-25 | — | — | WO | claimed |
| US-20100286386-A1 | Combinatorial production of nucleotide and nucleoside (XiTP) analogues | INSTITUT PASTEUR | 2010-11-11 | — | — | US | claimed |
| EP-1290006-B1 | Combinatorial production of nucleotide and nucleoside (XITP) analogues | PASTEUR INSTITUT (FR) | 2007-02-21 | — | — | EP | claimed |
| US-20040023240-A1 | Combinatorial production of nucleotide and nucleoside(xitp)analogues | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2004-02-05 | — | — | US | claimed |
| WO-2003070741-A1 | PHOSPHORAMIDITES AND USE THEREOF IN THE PREPARATION OF OLIGONUCLEOTIDES | CENTRE NATIONAL DE RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2003-08-28 | — | — | WO | claimed |
| US-4956477-A | Synthesis of 1,2-dioxetanes | TROPIX, INC. (US) | 1990-09-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040023240-A1 | Combinatorial production of nucleotide and nucleoside(xitp)analogues | TYMP, PNP, DPYD | TSHR 3150/4885CTSA 4667/4885ACHE 3129/4885 |
| US-20100286386-A1 | Combinatorial production of nucleotide and nucleoside (XiTP) analogues | TYMP, PNP, DPYD | TSHR 2696/4885CTSA 4460/4885ACHE 2806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.